Physician profile
Christopher James Macri
NPI 1912093105
$10,035.45
in general payments reported to CMS, 2019-2025
12 companies · $100 in 2025
The $100 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,768 · 2020: $276 · 2021: $73.71 · 2022: $436 · 2023: $369 · 2024: $13.12 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $7,464.54 | 2019-2023 | Nobelactive |
| Sirona Dental, INC. | $1,500.00 | 2019 | |
| Align Technology, INC. | $730.20 | 2019-2022 | |
| Dentsply Sirona INC | $119.23 | 2020-2023 | Suresmile |
| Septodont INC. | $72.93 | 2020 | |
| Envista Holdings Corporation | $68.39 | 2025 | Round Bur #6 |
| Voco America INC. | $16.50 | 2025 | Futurabond U, Grandio So Heavy Flow, Bifix Qm |
| Elevate Oral Care | $15.53 | 2025 | Fluorimax Mint, Advantage Arrest, Fluorimax 5000 |
| Philips North America LLC | $13.95 | 2019 | |
| Ultradent Products INC | $13.12 | 2024 | |
| Neoss, INC. | $11.05 | 2021 | |
| Sonendo INC | $10.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Macri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.